[PLX] YoY Quarter Result on 30-Jun-2015 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- 15.09%
YoY- 17.13%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 2,006 6,358 1,769 4,616 2,686 3,064 26,113 -34.78%
PBT -11,294 450 -10,736 -5,071 -6,119 -6,837 22 -
Tax 75 3,045 213 43 202 0 -8,765 -
NP -11,294 450 -10,853 -5,071 -6,119 -6,837 9,642 -
Tax Rate - -676.67% - - - - 39,840.91% -
Total Cost 13,300 5,908 12,622 9,687 8,805 9,901 16,471 -3.49%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin -563.01 7.08 -613.51 -109.86 -227.81 -223.14 36.92 -
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS -0.77 0.04 -0.11 -0.05 -0.07 -0.07 0.11 -
EPS Diluted -0.77 -0.60 -0.11 -0.05 -0.07 -0.07 0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.